81 results
Page 2 of 5
8-K
EX-99.1
mpi 3mm65v
8 May 23
Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors
8:45am
424B4
gcq5n1pcwo42wdvr2
2 Dec 22
Prospectus supplement with pricing info
5:40pm
8-K
EX-10.2
exb n3xjh5su9lid
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.1
5r5c984abs8
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-99.1
350fmtdb bkv0cyq2
24 Oct 22
Other Events
5:15pm
8-K
EX-99.1
0op7i70yrj3mfsrppt8
15 Aug 22
CNS Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:09am
8-K
EX-99.1
kn4ays 5xylpwhp
16 May 22
CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:38pm
424B3
g27n3e kjsqt9
1 Feb 22
Prospectus supplement
12:00am